Merck Animal Health Launches Dairy C.A.R.E. Initiative Resources to Support Optimal Animal Care

SUMMIT, N.J., September 30, 2014 – Merck Animal Health today introduced a new Dairy C.A.R.E. initiative to support the significant efforts of dairy producers to provide the best quality care for their animals. An extension of the Dairy Care365™ program, this new initiative focuses on providing resources on animal husbandry practices and hiring. Dairy C.A.R.E. also offers communication resources to help producers enhance awareness and understanding of their commitment to animals within their own communities.

“When it comes to managing a productive dairy operation, there are a lot of parts that need to be moving in harmony, and it’s important that we provide our customers with more than products to help them achieve success,” said Scott Nordstrom, D.V.M., director of dairy technical services for Merck Animal Health. “Training and maintaining sound policies and practices are critical to that success. They also help a producer to establish very clear performance expectations for employees who are hands on with the animals every day.”

Developed with input from veterinarians, university experts and dairy farmers, Dairy C.A.R.E. includes workforce resources, sample animal care commitment statements and policies, and standard operating procedures (SOPs) that outline how animals should be handled to optimize their health and well-being. Working with their veterinarians, dairy farmers can customize these materials to meet the specific needs of their farm or use them to enhance the programs.

The initiative also includes the Dairy Care365™ animal handling training videos that feature real on-farm settings to provide a realistic representation of how cows behave and react to their surroundings. Through these videos, employees learn how to work with dairy cattle and youngstock safely and effectively, move cows to the milking parlor and handle non-ambulatory cows. Available in English and Spanish, every video concludes with testing to gauge employee understanding of the material.

Merck Animal Health is offering hands-on Dairy C.A.R.E. workshops to help farmers customize the materials for their farms, which are free and open to farmers who register for the Dairy Care365TM program. For more information about the Dairy C.A.R.E. initiative and workshops, visit, or e-mail

About Merck Animal Health
Today’s Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit or connect with us on LinkedIn and Twitter at @MerckAH.

Merck Forward-Looking Statement
This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2013 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (